6533b825fe1ef96bd1282618
RESEARCH PRODUCT
KRAS and BRAF as prognostic biomarkers in patients undergoing surgical resection of colorectal cancer liver metastasis: A systematic review and meta-analysis.
Giuseppe BronteGiuseppe CiceroFrancesco PassigliaEmmanuela MussoAntonio RussoA. GuariniSalvatore VieniValentina CalòSergio RizzoL. CastellanaChristian RolfoNadia BarracoR. MaraglianoL. InsalacoAngela ListìViviana BazanMarta CastigliaEnrico BronteAntonio Galvanosubject
OncologySurgical resectionCancer Researchmedicine.medical_specialtyendocrine system diseasesColorectal cancerbusiness.industrymedicine.diseasemedicine.disease_causedigestive system diseasesMetastasisClinical trialOncologyInternal medicineMeta-analysismedicineIn patientKRASbusinessSurgical treatmentneoplasmsdescription
3565Background: Clinical trials investigated the potential role of both KRAS and BRAF mutations, as prognostic biomarkers, in colorectal cancer (CRC) patients who underwent surgical treatment of li...
year | journal | country | edition | language |
---|---|---|---|---|
2016-05-20 | Journal of Clinical Oncology |